77 related articles for article (PubMed ID: 28952223)
1. Protein Z (PZ) and plasminogen activator inhibitor-1 (PAI-1) plasma levels in patients with previously untreated Hodgkin lymphoma (HL).
Boutsikas G; Terpos E; Markopoulos A; Papatheodorou A; Stefanou A; Georgiou G; Galani Z; Komninaka V; Telonis V; Anagnostopoulos I; Dimitrakopoulou L; Anargyrou K; Tsionos K; Christoulas D; Gonianaki M; Giannikos T; Kokoris S; Konstantopoulos K; Meletis J; Angelopoulou MK; Travlou A; Vassilakopoulos TP
J BUON; 2017; 22(4):1022-1031. PubMed ID: 28952223
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen activator inhibitor-1 is elevated in patients with COPD independent of metabolic and cardiovascular function.
Waschki B; Watz H; Holz O; Magnussen H; Olejnicka B; Welte T; Rabe KF; Janciauskiene S
Int J Chron Obstruct Pulmon Dis; 2017; 12():981-987. PubMed ID: 28356730
[TBL] [Abstract][Full Text] [Related]
3. Proteins of the fibrinolytic system in human thrombi.
Robbie LA; Bennett B; Croll AM; Brown PA; Booth NA
Thromb Haemost; 1996 Jan; 75(1):127-33. PubMed ID: 8713791
[TBL] [Abstract][Full Text] [Related]
4. Type 1 plasminogen activator inhibitor is not an acute phase reactant in rats. Lack of IL-6- and hepatocyte-dependent synthesis.
Podor TJ; Hirsh J; Gelehrter TD; Zeheb R; Torry D; Guigoz Y; Sierra F; Gauldie J
J Immunol; 1993 Jan; 150(1):225-35. PubMed ID: 7678029
[TBL] [Abstract][Full Text] [Related]
5. The relationship of plasminogen activator inhibitor-1 levels to the ST deviation pattern of acute myocardial infarction.
Rott D; Leibowitz D; Finci-Yeheskel Z; Barak V; Chajek-Shaul T; Weiss T; Levin M; Urieli-Shoval S
Cardiology; 2009; 112(1):56-9. PubMed ID: 18580060
[TBL] [Abstract][Full Text] [Related]
6. Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition.
Pinsky DJ; Liao H; Lawson CA; Yan SF; Chen J; Carmeliet P; Loskutoff DJ; Stern DM
J Clin Invest; 1998 Sep; 102(5):919-28. PubMed ID: 9727060
[TBL] [Abstract][Full Text] [Related]
7. Plasma Concentrations of Protein Z and Protein Z-Dependent Protease Inhibitor in Patients With Essential Thrombocythemia.
Szumowska A; Galar M; Bolkun L; Kloczko J
Clin Appl Thromb Hemost; 2016 Oct; 22(7):679-84. PubMed ID: 25783867
[TBL] [Abstract][Full Text] [Related]
8. Increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels in patients with primary hyperparathyroidism.
Erem C; Kocak M; Nuhoglu I; Yilmaz M; Ucuncu O
Eur J Endocrinol; 2009 May; 160(5):863-8. PubMed ID: 19233920
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic values of plasma levels of fibrinolytic markers in ovarian cancer.
Ho CH; Yuan CC; Liu SM
Gynecol Oncol; 1999 Dec; 75(3):397-400. PubMed ID: 10600296
[TBL] [Abstract][Full Text] [Related]
10. Functional stability of plasminogen activator inhibitor-1.
Yasar Yildiz S; Kuru P; Toksoy Oner E; Agirbasli M
ScientificWorldJournal; 2014; 2014():858293. PubMed ID: 25386620
[TBL] [Abstract][Full Text] [Related]
11. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study.
Festa A; D'Agostino R; Tracy RP; Haffner SM;
Diabetes; 2002 Apr; 51(4):1131-7. PubMed ID: 11916936
[TBL] [Abstract][Full Text] [Related]
12. Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) treated successfully with tissue plasminogen activator.
Deng A; Gocke CD; Hess J; Heyman M; Paltiel M; Gaspari A
Arch Dermatol; 2006 Nov; 142(11):1466-9. PubMed ID: 17116837
[TBL] [Abstract][Full Text] [Related]
13. Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects.
Kruszynska YT; Yu JG; Olefsky JM; Sobel BE
Diabetes; 2000 Apr; 49(4):633-9. PubMed ID: 10871202
[TBL] [Abstract][Full Text] [Related]
14. Genetic architecture of tissue-type plasminogen activator and plasminogen activator inhibitor-1.
Asselbergs FW; Pattin K; Snieder H; Hillege HL; van Gilst WH; Moore JH
Semin Thromb Hemost; 2008 Sep; 34(6):562-8. PubMed ID: 19085655
[TBL] [Abstract][Full Text] [Related]
15. Residual vein thrombosis and onset of post-thrombotic syndrome: influence of the 4G/5G polymorphism of plasminogen activator inhibitor-1 gene.
Incalcaterra E; Meli F; Muratori I; Corrado E; Amato C; Canino B; Ferrara F
Thromb Res; 2014 Mar; 133(3):371-4. PubMed ID: 24485402
[TBL] [Abstract][Full Text] [Related]
16. Acute psychological stress decreases plasma tissue plasminogen activator (tPA) and tissue plasminogen activator/plasminogen activator inhibitor-1 (tPA/PAI-1) complexes in cardiac patients.
Hevey D; McGee HM; Fitzgerald D; Horgan JH
Eur J Appl Physiol; 2000 Nov; 83(4 -5):344-8. PubMed ID: 11138573
[TBL] [Abstract][Full Text] [Related]
17. [The plasma levels of urokinase plasminogen activator and urokinase plasminogen activator receptor and plasminogen activator inhibitor-1 in patients with different stages of liver cirrhosis following chronic hepatitis B].
Wu XR; Wang Q; Shi SS; Lu MH; Guo WD
Zhonghua Gan Zang Bing Za Zhi; 2004 Feb; 12(2):82-4. PubMed ID: 14980106
[TBL] [Abstract][Full Text] [Related]
18. Laboratory evidence of hyperfibrinolysis in association with low plasminogen activator inhibitor type 1 activity.
Agren A; Wiman B; Schulman S
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):657-60. PubMed ID: 17890953
[TBL] [Abstract][Full Text] [Related]
19. Development of a plasminogen activator inhibitor (PAI-1) assay and comparison of plasma PAI-1 activity in hyperlipidemic/dyslipidemic dogs with either hyperadrenocorticism or diabetes mellitus, and healthy dogs.
Wong CJ; Koch M; Behling-Kelly EL
Res Vet Sci; 2017 Apr; 111():1-8. PubMed ID: 28266313
[TBL] [Abstract][Full Text] [Related]
20. Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 levels in acute myocardial infarction.
Ganti AK; Potti A; Yegnanarayan R
Pathophysiol Haemost Thromb; 2002; 32(2):80-4. PubMed ID: 12214153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]